Literature DB >> 1477090

The HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians.

S Djoulah1, I Khalil, J P Beressi, S Benhamamouch, K Bessaoud, I Deschamps, L Degos, J Hors.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) in Caucasians is strongly associated with HLA-DR3-DQ2 and DR4-DQ8. In order to investigate the HLA class II associations with IDDM in Algerians, we have used polymerase chain reaction (PCR) and sequence specific oligonucleotide analysis (SSO) to identify DQA1, DQB1, and DRB1 alleles, haplotypes and genotypes in 50 unrelated IDDM patients and 46 controls from a homogeneous population in Western Algeria. Both DRB1*0301-DQA1*0501-DQB1*0201 (DR3-DQ2) and DRB1*04-DQA1*0301-DQB1*0302 (DR4-DQ8) haplotypes were found at increased frequencies among the patients compared to controls (45% vs. 13%, RR = 5.5, Pc < 10(-5) and 37% vs. 4%, RR = 12.9, Pc < 10(-4), respectively). Among the latter, in contrast to other Caucasian populations, only DRB1*0405-DQA1*0301-DQB1*0302 was significantly increased in the Algerian patients (25% vs. 1% in controls, RR = 30.3, Pc < 10(-3). Accordingly, the highest risk of disease was observed in DRB1*0301-DQA1*0501-DQB1*0201/DRB1*0405-DQA1+ ++*0301-DQB1*0302 heterozygotes (34% in patients vs. 0% in controls; RR = 49; Pc < 10(-3). This observation and its comparison with DR-DQ haplotypes in other ethnic groups suggest that the DRB1*0405 allele which encodes an Asp57-negative beta chain may contribute to IDDM susceptibility in a similar way as Asp57-negative DQ beta chains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477090     DOI: 10.1111/j.1744-313x.1992.tb00081.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  2 in total

Review 1.  Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries.

Authors:  Hatem Zayed
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

2.  HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.

Authors:  Mourad Aribi; Soraya Moulessehoul; Ahmed-Bakir Benabadji; Mohammed Kendoucitani
Journal:  BMC Genet       Date:  2004-08-24       Impact factor: 2.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.